Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients-Reference-Cited by-同舟云学术

Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients

Published:2023-11-22 Issue:12 Volume:31 Page:
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Minta Abena,Rose Lucy,Park Candice,Ramaswamy Bhuvaneswari,Stover Daniel,Gatti-Mays Margaret,Cherian Mathew,Williams Nicole,Sudheendra Preeti,Wesolowski Robert,Sardesai Sagar,Lustberg Maryam,Loprinzi Charles L.,Ruddy Kathryn J.,Cathcart-Rake Elizabeth,Trovato Stephanie,Dulmage Brittany

Funder

Pelotonia

Dermatology Foundation

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-023-08160-0.pdf

Reference31 articles.

1. Eiger D, Wagner M, Pondé NF, Nogueira MS et al (2020) The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC). Acta Oncol 59(6):723–725

2. Beusterien K, Maculaitis MC, Hallissey B et al (2021) Patient, oncologist, and payer preferences for adjuvant endocrine therapy and CDK4/6 inhibitor regimens in early-stage breast cancer: a discrete choice experiment. Patient Prefer Adherence 15:611–623. https://doi.org/10.2147/PPA.S298670

3. Saggar V, Wu S, Dickler MN, Lacouture ME (2013) Alopecia with endocrine therapies in patients with cancer. Oncologist 18(10):1126–1134. https://doi.org/10.1634/theoncologist.2013-0193

4. Silvestri M, Cristaudo A, Morrone A et al (2021) Emerging skin toxicities in patients with breast cancer treated with new cyclin-dependent kinase 4/6 inhibitors: a systematic review. Drug Saf 44(7):725–732

5. Chan D, Freites Martinez AD, Goldfarb SB et al (2019) CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients. J Clin Oncol 37(15_suppl):e 12537. https://doi.org/10.1200/JCO.2019.37.15_suppl.e12537

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis;Journal of Advanced Research;2024-07